Halozyme Therapeutics (HALO) Amortization - Intangibles (2022 - 2026)
Halozyme Therapeutics' Amortization - Intangibles was $29.51 million in Q2 2026, up 66.2% from $17.76 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Amortization - Intangibles (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, Halozyme Therapeutics' Amortization - Intangibles was $100.16 million through Jun 30, 2026, up 41.0% year-over-year; for FY2025, it came in at $76.66 million, up 7.9% from FY2024.
- Amortization - Intangibles shows a three-year compound annual growth rate of 21.1% (FY2022 to FY2025).
- In earlier years, Amortization - Intangibles was $71.05 million in FY2024 (-3.7%), $73.77 million in FY2023 (+71.0%) and $43.15 million in FY2022.
- Compared with a year earlier, Amortization - Intangibles has increased for three straight quarters, with growth averaging 18.9% over the last eight quarters.
- The best year-over-year quarter for Amortization - Intangibles over five years was Q4 2023 (growth of 290.2%); the worst was Q3 2023 (a decline of 25.2%).
- Per Business Quant data, HALO's Amortization - Intangibles in the three quarters before Q2 2026 was $29.51 million (Q1 2026), $23.38 million (Q4 2025) and $17.76 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Halozyme Therapeutics | 12.20 Bn | 10.80 Bn | 401.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.51 Mn |
| Mar 31, 2026 | 29.51 Mn |
| Dec 31, 2025 | 23.38 Mn |
| Sep 30, 2025 | 17.76 Mn |
| Jun 30, 2025 | 17.76 Mn |
| Mar 31, 2025 | 17.76 Mn |
| Dec 31, 2024 | 17.76 Mn |
| Sep 30, 2024 | 17.76 Mn |
| Jun 30, 2024 | 17.76 Mn |
| Mar 31, 2024 | 17.76 Mn |
| Dec 31, 2023 | 17.76 Mn |
| Sep 30, 2023 | 20.34 Mn |
| Jun 30, 2023 | 17.84 Mn |
| Mar 31, 2023 | 17.84 Mn |
| Dec 31, 2022 | 4.55 Mn |
| Sep 30, 2022 | 27.19 Mn |
| Jun 30, 2022 | 11.40 Mn |
API Access
Halozyme Therapeutics Amortization - Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=amortization-intangibles&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "amortization-intangibles", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=amortization-intangibles&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();